(Q38067440)

28 August 2017

1 reference

title

Molecular pathology of endometrial carcinoma (English)

1 reference

28 August 2017

0 references

Xavier Matias-Guiu Guia

series ordinal

1

object named as

Xavier Matias-Guiu

1 reference

28 August 2017

Jaime Prat

2

1 reference

28 August 2017

publication date

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

62

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

111-123

1 reference

Two pathogenetic types of endometrial carcinoma

28 August 2017

cites work

1 reference

Molecular pathology of endometrial hyperplasia and carcinoma

21 January 2018

1 reference

Endometrial carcinoma: pathology and genetics.

21 January 2018

1 reference

Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints

21 January 2018

1 reference

Microsatellite instability in sporadic endometrial carcinoma

21 January 2018

1 reference

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

21 January 2018

1 reference

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

Deletion mapping on chromosome 10q25-q26 in human endometrial cancer

21 January 2018

1 reference

Essential role for nuclear PTEN in maintaining chromosomal integrity

21 January 2018

1 reference

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 January 2018

1 reference

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

21 January 2018

1 reference

A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas

21 January 2018

1 reference

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

21 January 2018

1 reference

Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma

21 January 2018

1 reference

Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations

21 January 2018

1 reference

PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer

21 January 2018

1 reference

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

21 January 2018

1 reference

Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma

21 January 2018

1 reference

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

21 January 2018

1 reference

Drug-sensitive FGFR2 mutations in endometrial carcinoma

21 January 2018

1 reference

Mutations of the beta-catenin gene in endometrial carcinomas.

21 January 2018

1 reference

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

21 January 2018

1 reference

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

21 January 2018

1 reference

Molecular alterations in uterine serous carcinoma

21 January 2018

1 reference

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

21 January 2018

1 reference

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer

21 January 2018

1 reference

Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium.

21 January 2018

1 reference

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

21 January 2018

1 reference

MicroRNA signatures differentiate uterine cancer tumor subtypes

21 January 2018

1 reference

Prognostic significance of miR-205 in endometrial cancer

21 January 2018

1 reference

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer

21 January 2018

1 reference

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

21 January 2018

1 reference

Long, abundantly expressed non-coding transcripts are altered in cancer

21 January 2018

1 reference

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

21 January 2018

1 reference

FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis

21 January 2018

1 reference

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

21 January 2018

1 reference

CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

21 January 2018

1 reference

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

21 January 2018

1 reference

Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia.

21 January 2018

1 reference

Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner.

21 January 2018

1 reference

PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

21 January 2018

1 reference

NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.

21 January 2018

1 reference

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas

21 January 2018

1 reference

The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

21 January 2018

1 reference

Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants

21 January 2018

1 reference

Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

21 January 2018

1 reference

Low Frequency of BRAF Mutations in Endometrial and in Cervical Carcinomas

21 January 2018

1 reference

FGFR2 alterations in endometrial carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12053

1 reference

OpenCitations bibliographic resource ID

28 August 2017

541

0 references

1 reference